Autopsy report · NCT00849888

Serum-Free Thymus Transplantation in DiGeorge Anomaly

“The sponsor decided to withdraw the study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months after it had already started.
• Ran for about 2 years 10 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Sumitomo Pharma Switzerland GmbH

Sponsor type

Industry

Conditions

DiGeorge Anomaly

Interventions

Serum Free Thymus Transplantation with Immunosuppression; Serum Free Thymus Transplantation without immunosuppression

Participants

2

Trials that died the same way

• Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors
  “The sponsor withdrawed the sponsorship to the study.” (95% match in meaning)
• NRX-1074 in Early Course Schizophrenia
  “The study was withdrawn by the sponsor.” (93% match in meaning)
• Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
  “Sponsor withdrew the study” (92% match in meaning)
• A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a
  “Sponsor decision to withdraw study at this time.” (90% match in meaning)
• A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants
  “Study was Withdrawn per Sponsor decision.” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.